Sign in
TXG Stock Price, Chart, Stats & News
10x Genomics, Inc.
Save
4.05B
Market cap
–
Current P/E
555.56x
Forward P/E
TXG chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 69.05% |
Operating margin | -9.49% |
Pretax margin | -6.21% |
Net margin | -6.77% |
Effective tax rate | -9.11% |
ROA | -4.18% |
ROE | -5.69% |
D/E | 0.20x |
Interest coverage ratio | -10164.17x |
TXG valuation
P/E | – |
P/S | 3.87x |
P/B | 3.11x |
P/CF | 18.20x |
P/FCF | 19.13x |
P/OCF | 18.20x |
PEG | -1.31x |
EV multiple | -223.80x |
About
Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012 and known as 10X Technologies, Inc. until November 2014) is a prominent life science technology company. The firm specializes in creating and distributing sophisticated instrumentation, essential consumables, and software designed for in-depth analysis of biological systems. Its market presence extends globally, covering North America, Europe, the Middle East, Africa, China, and the Asia Pacific.
Similar securities
Based on sector and market capitalization
Report issue